Analyst Douglas Miehm works at RBC and is focused on the Healthcare sector with 56 price targets and ratings documented since 2018 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 28.54% with an average time for price targets to be met of 131.67 days.
Most recent stock forecast was given on AUPH, Aurinia Pharmaceuticals Inc at 04-Nov-2022.
Douglas Miehm best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS INC).
The best stock recommendation documented was for AUPH (AURINIA PHARMACEUTICALS INC) at 12/5/2019. The price target of $20 was fulfilled within 19 days with a profit of $5 (33.33%) receiving and performance score of 17.54.
Average potential price target upside